These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33412411)

  • 1. Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques.
    Ishigaki H; Nakayama M; Kitagawa Y; Nguyen CT; Hayashi K; Shiohara M; Gotoh B; Itoh Y
    Virology; 2021 Feb; 554():97-105. PubMed ID: 33412411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8
    Ishii H; Nomura T; Yamamoto H; Nishizawa M; Thu Hau TT; Harada S; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Suzuki T; Park ES; Ken M; Onodera T; Takahashi Y; Kusano K; Shimazaki R; Suzaki Y; Ami Y; Matano T
    Cell Rep Med; 2022 Feb; 3(2):100520. PubMed ID: 35233545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques.
    Nomura T; Yamamoto H; Nishizawa M; Hau TTT; Harada S; Ishii H; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Iida S; Katano H; Suzuki T; Park ES; Maeda K; Suzaki Y; Ami Y; Matano T
    PLoS Pathog; 2021 Jul; 17(7):e1009668. PubMed ID: 34280241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
    Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H
    mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
    Chandrashekar A; Liu J; Martinot AJ; McMahan K; Mercado NB; Peter L; Tostanoski LH; Yu J; Maliga Z; Nekorchuk M; Busman-Sahay K; Terry M; Wrijil LM; Ducat S; Martinez DR; Atyeo C; Fischinger S; Burke JS; Slein MD; Pessaint L; Van Ry A; Greenhouse J; Taylor T; Blade K; Cook A; Finneyfrock B; Brown R; Teow E; Velasco J; Zahn R; Wegmann F; Abbink P; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kordana N; Li Z; Lifton MA; Mahrokhian SH; Maxfield LF; Nityanandam R; Nkolola JP; Schmidt AG; Miller AD; Baric RS; Alter G; Sorger PK; Estes JD; Andersen H; Lewis MG; Barouch DH
    Science; 2020 Aug; 369(6505):812-817. PubMed ID: 32434946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.
    Li D; Luan N; Li J; Zhao H; Zhang Y; Long R; Jiang G; Fan S; Xu X; Cao H; Wang Y; Liao Y; Wang L; Liu L; Liu C; Li Q
    Emerg Microbes Infect; 2021 Dec; 10(1):2194-2198. PubMed ID: 34736354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.
    Sulbaran G; Maisonnasse P; Amen A; Effantin G; Guilligay D; Dereuddre-Bosquet N; Burger JA; Poniman M; Grobben M; Buisson M; Dergan Dylon S; Naninck T; Lemaître J; Gros W; Gallouët AS; Marlin R; Bouillier C; Contreras V; Relouzat F; Fenel D; Thepaut M; Bally I; Thielens N; Fieschi F; Schoehn G; van der Werf S; van Gils MJ; Sanders RW; Poignard P; Le Grand R; Weissenhorn W
    Cell Rep Med; 2022 Feb; 3(2):100528. PubMed ID: 35233549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions.
    Urano E; Okamura T; Ono C; Ueno S; Nagata S; Kamada H; Higuchi M; Furukawa M; Kamitani W; Matsuura Y; Kawaoka Y; Yasutomi Y
    Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34625475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
    Shan C; Yao YF; Yang XL; Zhou YW; Gao G; Peng Y; Yang L; Hu X; Xiong J; Jiang RD; Zhang HJ; Gao XX; Peng C; Min J; Chen Y; Si HR; Wu J; Zhou P; Wang YY; Wei HP; Pang W; Hu ZF; Lv LB; Zheng YT; Shi ZL; Yuan ZM
    Cell Res; 2020 Aug; 30(8):670-677. PubMed ID: 32636454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
    Deng W; Bao L; Liu J; Xiao C; Liu J; Xue J; Lv Q; Qi F; Gao H; Yu P; Xu Y; Qu Y; Li F; Xiang Z; Yu H; Gong S; Liu M; Wang G; Wang S; Song Z; Liu Y; Zhao W; Han Y; Zhao L; Liu X; Wei Q; Qin C
    Science; 2020 Aug; 369(6505):818-823. PubMed ID: 32616673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.
    Brouwer PJM; Brinkkemper M; Maisonnasse P; Dereuddre-Bosquet N; Grobben M; Claireaux M; de Gast M; Marlin R; Chesnais V; Diry S; Allen JD; Watanabe Y; Giezen JM; Kerster G; Turner HL; van der Straten K; van der Linden CA; Aldon Y; Naninck T; Bontjer I; Burger JA; Poniman M; Mykytyn AZ; Okba NMA; Schermer EE; van Breemen MJ; Ravichandran R; Caniels TG; van Schooten J; Kahlaoui N; Contreras V; Lemaître J; Chapon C; Fang RHT; Villaudy J; Sliepen K; van der Velden YU; Haagmans BL; de Bree GJ; Ginoux E; Ward AB; Crispin M; King NP; van der Werf S; van Gils MJ; Le Grand R; Sanders RW
    Cell; 2021 Mar; 184(5):1188-1200.e19. PubMed ID: 33577765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients.
    Mohn KG; Bredholt G; Zhou F; Madsen A; Onyango TB; Fjelltveit EB; Jalloh SL; Brokstad KA; Cantoni D; Mayora-Neto M; Temperton N; Langeland N; Cox RJ;
    PLoS One; 2022; 17(2):e0261979. PubMed ID: 35192617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.
    Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH
    Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection.
    Melton A; Rowe LA; Penney T; Krzykwa C; Goff K; Scheuermann SE; Melton HJ; Williams K; Golden N; Green KM; Smith B; Russell-Lodrigue K; Dufour JP; Doyle-Meyers LA; Schiro F; Aye PP; Lifson JD; Beddingfield BJ; Blair RV; Bohm RP; Kolls JK; Rappaport J; Hoxie JA; Maness NJ
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long road.
    Cohen J
    Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques.
    Garrido C; Curtis AD; Dennis M; Pathak SH; Gao H; Montefiori D; Tomai M; Fox CB; Kozlowski PA; Scobey T; Munt JE; Mallory ML; Saha PT; Hudgens MG; Lindesmith LC; Baric RS; Abiona OM; Graham B; Corbett KS; Edwards D; Carfi A; Fouda G; Van Rompay KKA; De Paris K; Permar SR
    Sci Immunol; 2021 Jun; 6(60):. PubMed ID: 34131024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques.
    Van Rompay KKA; Olstad KJ; Sammak RL; Dutra J; Watanabe JK; Usachenko JL; Immareddy R; Verma A; Shaan Lakshmanappa Y; Schmidt BA; Roh JW; Elizaldi SR; Allen AM; Muecksch F; Lorenzi JCC; Lockwood S; Pollard RE; Yee JL; Nham PB; Ardeshir A; Deere JD; Patterson J; Dang Q; Hatziioannou T; Bieniasz PD; Iyer SS; Hartigan-O'Connor DJ; Nussenzweig MC; Reader JR
    PLoS Pathog; 2021 Jul; 17(7):e1009688. PubMed ID: 34228761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.
    Pillet S; Arunachalam PS; Andreani G; Golden N; Fontenot J; Aye PP; Röltgen K; Lehmicke G; Gobeil P; Dubé C; Trépanier S; Charland N; D'Aoust MA; Russell-Lodrigue K; Monjure C; Blair RV; Boyd SD; Bohm RP; Rappaport J; Villinger F; Landry N; Pulendran B; Ward BJ
    Cell Mol Immunol; 2022 Feb; 19(2):222-233. PubMed ID: 34983950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.